References
Gordon C.T., State R.C., Nelson J.E., Hamburger S.D., Rapoport J.L., (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder Archives of General Psychiatry 50:441–447
Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., Wasserman S., Iyengar R., (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism Neuropsychopharmacology 30:582–589
McDougle C.J., Kresch L.E., Posey D.J., (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors Journal of Autism and Developmental Disorders 30(5):427–435
McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H., (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder Archives of General Psychiaty 53:1001–1008
McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., Arnold L.E., Posey D.J., Martin A., Ghuman J.K., Shah B., Chuang S.Z., Swiezy N.B., Gonzalez N.M., Hollway J., Koenig K., McGough J.J., Ritz L., Vitiello B., (in press) Risperidone for the core symptom domains of autism: Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry 162:1142–1148
Research Units on Pediatric Psychopharmacology Autism Network (2002). Risperidone in children with autism and serious behavioral problems New England Journal of Medicine 347(5):314–321
Author information
Authors and Affiliations
Corresponding author
Additional information
JADD October 2005
Rights and permissions
About this article
Cite this article
McDougle, C.J. Ask the Editor. J Autism Dev Disord 35, 687–688 (2005). https://doi.org/10.1007/s10803-005-0013-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-005-0013-x